J&J Moves To Dismiss Amended Complaint In Fiduciary Breach Row Over Drug Benefits

(July 9, 2024, 8:47 AM EDT) -- CAMDEN, N.J. — Johnson and Johnson and the committee that administers the health plans the company sponsors have moved in New Jersey federal court to dismiss the amended complaint in a high-profile putative class Employee Retirement Income Security Act fiduciary duty suit focused on the plan’s pharmacy benefits manager (PBM) and prescription drug benefits....